Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 10
Submit an article Journal homepage
416
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

High expression levels of IP10/CXCL10 are associated with modulation of the natural killer cell compartment in multiple myeloma

Giovanni BernardiniDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy; ;IRCCS, Neuromed, Pozzilli, Isernia, Italy; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3705-2598View further author information
ORCID Icon,
Elisabetta VulpisDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy; View further author information
,
Valentina BonanniDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy; View further author information
,
Helena StabileDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy; View further author information
,
Maria Rosaria RicciardiDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy; ORCID Iconhttp://orcid.org/0000-0002-8772-3521View further author information
ORCID Icon,
Maria Teresa PetrucciDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy; View further author information
,
Angela GismondiDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy; View further author information
,
Angela SantoniIRCCS, Neuromed, Pozzilli, Isernia, Italy; ;Department of Molecular Medicine, Sapienza University of Rome, Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, ItalyView further author information
&
Alessandra ZingoniDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy; View further author information
 show all
Pages 2493-2496 | Received 18 Nov 2016, Accepted 07 Feb 2017, Published online: 28 Feb 2017

References

  • Carbone E, Neri P, Mesuraca M, et al. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood. 2005;105:251–258.
  • El-Sherbiny YM, Meade JL, Holmes TD, et al. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res. 2007;67:8444–8449.
  • Pogge von Strandmann E, Simhadri VR, von Tresckow B, et al. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity. 2007;27:965–974.
  • Swift BE, Williams BA, Kosaka Y, et al. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model. Haematologica. 2012;97:1020–1028.
  • Guillerey C, Ferrari de Andrade L, Vuckovic S, et al. Immunosurveillance and therapy of multiple myeloma are CD226 dependent. J Clin Invest. 2015;125:2904.
  • Zingoni A, Cecere F, Vulpis E, et al. Genotoxic stress induces senescence-associated ADAM10-dependent release of NKG2D MIC ligands in multiple myeloma cells. J Immunol. 2015;195:736–748.
  • Jinushi M, Vanneman M, Munshi NC, et al. MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma. Proc Natl Acad Sci USA. 2008;105:1285–1290.
  • Sawanobori M, Suzuki K, Nakagawa Y, et al. Natural killer cell frequency and serum cytokine levels in monoclonal gammopathies: correlation of bone marrow granular lymphocytes to prognosis. Acta Haematol. 1997;98:150–154.
  • Jurisic V, Srdic T, Konjevic G, et al. Clinical stage-depending decrease of NK cell activity in multiple myeloma patients. Med Oncol. 2007;24:312–317.
  • Ponzetta A, Benigni G, Antonangeli F, et al. Multiple myeloma impairs bone marrow localization of effector natural killer cells by altering the chemokine microenvironment. Cancer Res. 2015;75:4766–4777.
  • Ponzetta A, Sciume G, Benigni G, et al. CX3CR1 regulates the maintenance of KLRG1+ NK cells into the bone marrow by promoting their entry into circulation. J Immunol. 2013;191:5684–5694.
  • Bolomsky A, Schreder M, Hubl W, et al. Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma. Leuk Lymphoma. 2016;57:2516–2525.
  • Stabile H, Nisti P, Morrone S, et al. Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients. Haematologica. 2015;100:489–498.
  • Levi I, Amsalem H, Nissan A, et al. Characterization of tumor infiltrating natural killer cell subset. Oncotarget. 2015;6:13835–13843.
  • Pogge von Strandmann E, Shatnyeva O, Hansen HP. NKp30 and its ligands: emerging players in tumor immune evasion from natural killer cells. Ann Transl Med. 2015;3:314

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.